Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality

K Zsebo, A Yaroshinsky, JJ Rudy, K Wagner… - Circulation …, 2014 - Am Heart Assoc
Rationale: The Calcium Up-Regulation by Percutaneous Administration of Gene Therapy In
Cardiac Disease (CUPID 1) study was a phase 1/phase 2 first-in-human clinical gene …

Clinical/Translational Research

K Zsebo, A Yaroshinsky, JJ Rudy, K Wagner… - Circulation …, 2014 - Am Heart Assoc
Objective: To report long-term (3-year) clinical effects and transgene expression in the
patients in CUPID 1. Methods and Results: A total of 39 patients with advanced heart failure …

Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart Failure

K Zsebo, A Yaroshinsky, JJ Rudy, K Wagner… - Circulation …, 2014 - cir.nii.ac.jp
抄録< jats: sec>< jats: title>< jats: underline> Rationale:</jats: underline></jats: title>< jats:
p> The Calcium Up-Regulation by Percutaneous Administration of Gene Therapy In Cardiac …

[PDF][PDF] Clinical/Translational Research

K Zsebo, A Yaroshinsky, JJ Rudy, K Wagner… - Circulation …, 2014 - academia.edu
Objective: To report long-term (3-year) clinical effects and transgene expression in the
patients in CUPID 1. Methods and Results: A total of 39 patients with advanced heart failure …

Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality.

K Zsebo, A Yaroshinsky, JJ Rudy, K Wagner… - Circulation …, 2013 - europepmc.org
Objective To report long-term (3-year) clinical effects and transgene expression in the
patients in CUPID 1. Methods and results A total of 39 patients with advanced heart failure …

Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality

K Zsebo, A Yaroshinsky, JJ Rudy… - Circulation …, 2014 - pubmed.ncbi.nlm.nih.gov
Rationale The Calcium Up-Regulation by Percutaneous Administration of Gene Therapy In
Cardiac Disease (CUPID 1) study was a phase 1/phase 2 first-in-human clinical gene …